Surgery pp 709-727 | Cite as

Evidence-Based Bariatric Surgery

  • John Morton


An obesity epidemic exists throughout the developed and much of the developing world.1, 2, 3, 4 Obesity, typically measured as body mass index (BMI) of 30kg/m2 or higher, has three subclasses: obesity 1 (30–34.9); obesity 2 (35–39.9); and extreme obesity (>40). Extreme or morbid obesity is increasing particularly rapidly in the United States and may have the potential of decreasing life expectancy.5, 6, 7 From 1986 to 2000, the prevalence of BMI of 30 or more doubled, whereas that of BMI of 40 or more quadrupled, and even extreme obesity, BMI of 50 or more, increased fivefold.2 Of particular concern is the alarming increasing prevalence of obesity among children, suggesting that the epidemic will worsen before it improves.1


Bariatric Surgery Gastric Bypass Morbid Obesity Sleeve Gastrectomy Gastric Banding 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006;295:1549–1555.PubMedCrossRefGoogle Scholar
  2. 2.
    Leibson CL, Williamson DF, Melton LJ III, et al. Temporal trends in BMI among adults with diabetes. Diabetes Care 2001;24:1584–1589.PubMedCrossRefGoogle Scholar
  3. 3.
    Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg 2004;14:1157–1164.PubMedCrossRefGoogle Scholar
  4. 4.
    Yoon K, Lee J-H, Kim J-W, et al. Epidemic obesity and type 2 diabetes in Asia. Lancet 2006:368:1681–1686.PubMedCrossRefGoogle Scholar
  5. 5.
    Calle EE, Thun MJ, Petrelli JM. Body-mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999;341:1097–1105.PubMedCrossRefGoogle Scholar
  6. 6.
    Olshansky SJ, Passaro DJ, Hershow RC, et al. A potential decline in life expectancy in the United States in the 21st century. N Engl J Med 2005;352:1138–1145.PubMedCrossRefGoogle Scholar
  7. 7.
    Pinhas-Hamiel O, Dolan LM, Daniels SR, Standford D, Khoury PR, Zeitler P. Increased incidence of non-insulin diabetes among adolescents. J Pediatr 1996;128(5):608–615.PubMedCrossRefGoogle Scholar
  8. 8.
    Brown CD, Higgins M, Donato KA, et al. Body mass index and prevalence of hypertension and dyslipidemia. Obes Res 2000;348:1625–1638Google Scholar
  9. 9.
    Engeland A, Bjorge T, Sogaard AJ, Tverdal A. Body mass index in adolescence in relation to total mortality. Am J Epidemiol 2003;157(6):517–523.PubMedCrossRefGoogle Scholar
  10. 10.
    Fontaine KR, Redden DT, Wang C, et al. Years of life lost due to obesity. JAMA 2003;289:187–193.PubMedCrossRefGoogle Scholar
  11. 11.
    Wolf AM, Colditz GA. Current estimates of the economic cost of obesity in the United States. Obes Res 1998;6:97–106.PubMedGoogle Scholar
  12. 12.
    Lean MEJ, Powrie JK, Anderson AS, et al. Obesity, weight loss, and prognosis in type 2 diabetes. Diabet Med 1990;7:228–233.PubMedCrossRefGoogle Scholar
  13. 13.
    Malik S, Wong ND, Franklin SS, et al. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults. Circulation 2004;110:1245–1250.PubMedCrossRefGoogle Scholar
  14. 14.
    Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss. Circulation 2006;113:898–918.PubMedCrossRefGoogle Scholar
  15. 15.
    Kim KS, Owen WL, Williams D, Adams-Campbell LL. A comparison between BMI and conicity index on predicting coronary heart disease: the Framingham Heart Study. Ann Epidemiol 2000;10:424–431.PubMedCrossRefGoogle Scholar
  16. 16.
    Jonsson S, Hedblad B, Engstrom G, Nilsson P, Berglund G, Janzon L. Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes 2002;26:1046–1053.CrossRefGoogle Scholar
  17. 17.
    Stamler R, Stamler J, Riedlinger WF, et al. Weight and blood pressure: findings in hypertension screening of 1 million Americans. JAMA 1978;240:1607–1610.PubMedCrossRefGoogle Scholar
  18. 18.
    Garrison RJ, Kannel WB, Stokes J III, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Study. Prev Med 1987;16:235–251.PubMedCrossRefGoogle Scholar
  19. 19.
    Dixon JB, O’Brien P. A disparity between conventional lipid and insulin resistance markers at body mass index levels greater than 34kg/m2. Int J Obes Relat Metab Disord 2001;25:793–797.PubMedCrossRefGoogle Scholar
  20. 20.
    Vgontzas AN, Tan TL, Bixler EO, et al. Sleep apnea and sleep disruption in obese patients. Arch Intern Med 1994;154:1705–1711.PubMedCrossRefGoogle Scholar
  21. 21.
    Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. National Institutes of Health. Obes Res 1998;(suppl 2):51S–S209.Google Scholar
  22. 22.
    Houston DK, Stevens J, Cai J, et al. Role of weight history on functional limitations and disability in late adulthood: the ARIC study. Obes Res 2005;13:1793–1802.PubMedCrossRefGoogle Scholar
  23. 23.
    Schauer PR, Ikramuddin S, Gourash WC, Ramanathan R, Luketich J. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg 2000;232:515–529.PubMedCrossRefGoogle Scholar
  24. 24.
    Klein S, Mittendorfer B, Eagon JC, et al. Gastric bypass improves metabolic and hepatic abnormalities associated with non-alcoholic liver disease. Gastroenterology 2006;130(6):1564–1572.PubMedCrossRefGoogle Scholar
  25. 25.
    Fine JT, Colditz GA, Coakley EH, et al. A prospective study of weight change and health-related quality of life in women. JAMA 1999;282:2136–2142.PubMedCrossRefGoogle Scholar
  26. 26.
    Fellitti VJ. Childhood sexual abuse, depression, and family dysfunction in adult obese patients. South Med J 1993;86:732–736.CrossRefGoogle Scholar
  27. 27.
    Miller WC, Koceja DM, Hamilton EJ. A meta-analysis of the past 25 years of weight loss research using diet, exercise or diet plus exercise intervention. Int J Obes Relat Metab Disord 1997;21(10):941–947.PubMedCrossRefGoogle Scholar
  28. 28.
    Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 2002;346(21):1623–1630.PubMedCrossRefGoogle Scholar
  29. 29.
    Li Z, Maglione M, Tu W, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med 2005;142(7):532–546.PubMedGoogle Scholar
  30. 30.
    Anderson JW, Grant L, Gotthelf L, Stifler LT. Weight loss and long-term follow-up of severely obese individuals treated with an intense behavioral program. Int J Obes 2006;443–450.Google Scholar
  31. 31.
    Nordmann AJ, Nordmann A, Briel M, et al. Effects of low-carbohydrate vs. low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006;166(3):285–293.PubMedCrossRefGoogle Scholar
  32. 32.
    Despres JP, Golay A, Sjostrom L. Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005;353(20):2121–2134.PubMedCrossRefGoogle Scholar
  33. 33.
    Volmar KE, Hutchins GM. Aortic and mitral fenfluramine-phentermine valvulopathy in 64 patients treated with anorectic agents. Arch Pathol Lab Med 2001;125(12):1555–1561.PubMedGoogle Scholar
  34. 34.
    Consensus Development Conference Panel. Gastrointestinal surgery for severe obesity. Ann Intern Med 1991;115(12):956–961.Google Scholar
  35. 35.
    Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004;114:217–223.PubMedCrossRefGoogle Scholar
  36. 36.
    Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683–2693.PubMedCrossRefGoogle Scholar
  37. 37.
    Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004;292:1724–1737.PubMedCrossRefGoogle Scholar
  38. 38.
    Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005;142:547–559.PubMedGoogle Scholar
  39. 39.
    O’Brien PE, Dixon JB, Laurie C, et al. Treatment of mild to moderate obesity with laparoscopic adjustable gastric banding or an intensive medical program: a randomized trial. Ann Intern Med 2006;144:625–633.PubMedGoogle Scholar
  40. 40.
    Buchwald H, Varco RL, Boen JR, et al. Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Arch Intern Med 1998;158(11):1253–1261.PubMedCrossRefGoogle Scholar
  41. 41.
    Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg 2004;240:416–423; discussion 423–424.PubMedCrossRefGoogle Scholar
  42. 42.
    Santry HP, Gillen DL, Lauderdale DS. Trends in bariatric surgical procedures. JAMA 2005;294:1909–1917.PubMedCrossRefGoogle Scholar
  43. 43.
    Trus TL, Pope GD, Finlayson SRG. National trends in utilization and outcomes of bariatric surgery. Surg Endosc 2005;19(5):616–620.PubMedCrossRefGoogle Scholar
  44. 44.
    Griffen WO Jr, Young VL, Stevenson CC. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity. Ann Surg 1977;186(4):500–509.PubMedCrossRefGoogle Scholar
  45. 45.
    Laws HL, Piantadosi S. Superior gastric reduction procedure for morbid obesity: a prospective, randomized trial. Ann Surg 1981;193(3):334–340.PubMedCrossRefGoogle Scholar
  46. 46.
    Pories WJ, Flickinger EG, Meelheim D, et al. The effectiveness of gastric bypass over gastric partition in morbid obesity: consequence of distal gastric and duodenal exclusion. Ann Surg 1982;196(4):389–399.PubMedCrossRefGoogle Scholar
  47. 47.
    Andersen T, Pedersen BH, Dissing I, et al. A randomized comparison of horizontal and vertical banded gastroplasty: what determines weight loss? Scand J Gastroenterol 1989;24(2):186–192.PubMedCrossRefGoogle Scholar
  48. 48.
    Naslund I, Wickbom G, Christoffersson E, et al. A prospective randomized comparison of gastric bypass and gastroplasty. Complications and early results. Acta Chir Scand 1986;152:681–689.PubMedGoogle Scholar
  49. 49.
    Sugerman HJ, Starkey JV, Birkenhauer R. A randomized prospective trial of gastric bypass versus vertical banded gastroplasty for morbid obesity and their effects on sweets versus non-sweets eaters. Ann Surg 1987;205(6):613–624.PubMedCrossRefGoogle Scholar
  50. 50.
    Hall JC, Watts JM, O’Brien PE, et al. Gastric surgery for morbid obesity. The Adelaide Study. Ann Surg 1990;211(4):419–427.PubMedCrossRefGoogle Scholar
  51. 51.
    Weber M, Muller MK, Bucher T, et al. Laparoscopic gastric bypass is superior to laparoscopic gastric banding for treatment of morbid obesity. Ann Surg 2004;240(6):975–982; discussion 982–983.PubMedCrossRefGoogle Scholar
  52. 52.
    Skroubis G, Anesidis S, Kehagias I, et al. Roux-en-Y gastric bypass versus a variant of biliopancreatic diversion in a non-superobese population: prospective comparison of the efficacy and the incidence of metabolic deficiencies. Obes Surg 2006;16(4):488–495.PubMedCrossRefGoogle Scholar
  53. 53.
    Nilsell K, Thorne A, Sjostedt S, et al. Prospective randomised comparison of adjustable gastric banding and vertical banded gastroplasty for morbid obesity. Eur J Surg 2001;167(7):504–509.PubMedCrossRefGoogle Scholar
  54. 54.
    Morino M, Toppino M, Bonnet G, et al. Laparoscopic adjustable silicone gastric banding versus vertical banded gastroplasty in morbidly obese patients: a prospective randomized controlled clinical trial. Ann Surg 2003;238(6):835–842; discussion 841–842.PubMedCrossRefGoogle Scholar
  55. 55.
    Olbers T, Bjorkman S, Lindroos A, et al. Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial. Ann Surg 2006;244(5):715–722.PubMedCrossRefGoogle Scholar
  56. 56.
    Olbers T, Fagevik-Olsen M, Maleckas A, et al. Randomized clinical trial of laparoscopic Roux-en-Y gastric bypass versus laparoscopic vertical banded gastroplasty for obesity. Br J Surg 2005;92(5):557–562.PubMedCrossRefGoogle Scholar
  57. 57.
    Primrose JN, Davies JA, Prentice CR, Hughes R, Johnston D. Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity. Thromb Haemost 1992;68:396–399.PubMedGoogle Scholar
  58. 58.
    Kopp CW, Kopp HP, Steiner S, et al. Weight loss reduces tissue factor in morbidly obese patients. Obes Res 2003;11:950–960.PubMedCrossRefGoogle Scholar
  59. 59.
    Hanusch-Enserer U, Cauza E, Spak M, et al. Improvement of insulin resistance and early atherosclerosis in patients after gastric banding. Obes Res 2004;12:284–291.PubMedCrossRefGoogle Scholar
  60. 60.
    Schernthaner GH, Kopp HP, Kriwanek S, et al. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity. Obes Surg 2006;16:709–715.PubMedCrossRefGoogle Scholar
  61. 61.
    Schernthaner GH, Kopp HP, Krzyzanowska K, et al. Soluble CD40L in patients with morbid obesity: significant reduction after bariatric surgery. Eur J Clin Invest 2006;36:395–401.PubMedCrossRefGoogle Scholar
  62. 62.
    Krzyzanowska KA, Mittermayer F, Kopp HP, Wolzt M, Schernthaner G. Weight loss reduces circulating asymmetrical dimethylarginine concentrations in morbidly obese women. J Clin Endocr Metab 2004;89:6277–6281.PubMedCrossRefGoogle Scholar
  63. 63.
    Kopp HP, Spranger J, Mohlig M, Krzyzanowska K, Pfeiffer AFH, Schernthaner G. Effect of weight loss on plasma levels of adipo-nectin in association with markers of chronic subclinical inflammation and the insulin resistance syndrome in obese subjects. Int J Obes 2005;29:766–771.CrossRefGoogle Scholar
  64. 64.
    Blankenberg S, Tiret L, Bickel C, et al. Interleukin-18 is a strong predictor of cardiovascular death in stable and unstable angina. Circulation 2002;106:24–30.PubMedCrossRefGoogle Scholar
  65. 65.
    de Lemos JA, Morrow DA, Sabatine MS, et al. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation 2003;107:690–695.PubMedCrossRefGoogle Scholar
  66. 66.
    Heeschen C, Dimmeler S, Hamm CW, et al. Soluble CD40 ligand in acute coronary syndromes. N Engl J Med 2003;348:1104–1111.PubMedCrossRefGoogle Scholar
  67. 67.
    Williams B, Hagedorn J, Lawson E, et al. Gastric bypass reduces biochemical cardiac risk factors. Surg Obes Relat Dis 2007;3(1):8–13.PubMedCrossRefGoogle Scholar
  68. 68.
    Flum DR, Dellinger EP. Assessing the impact of bariatric surgery on survival. J Am Coll Surg 2004;199:543–551.PubMedCrossRefGoogle Scholar
  69. 69.
    MacDonald KG Jr, Long SD, Swanson MS, et al. The gastric bypass operation reduces the progression and mortality of non-insulin-dependent diabetes mellitus. J Gastrointest Surg 1997;1:213–220.PubMedCrossRefGoogle Scholar
  70. 70.
    Sjostrom L. Bariatric surgery in diabetic patients—what is the evidence? Presented at 42nd EASD Meeting, Copenhagen, 2006.Google Scholar
  71. 71.
    Barakat HA, Mooney N, O’Brien K, et al. Coronary heart disease risk factors in morbidly obese women with normal glucose tolerance. Diabetes Care 1993;16:144–149.PubMedCrossRefGoogle Scholar
  72. 72.
    Nguyen NT, Goldman C, Rosenquist CJ, et al. Laparoscopic versus open gastric bypass: a randomized study of outcomes, quality of life, and costs. Ann Surg 2001;234(3):279–289.PubMedCrossRefGoogle Scholar
  73. 73.
    Dymek M, le Grange D, Neven K, Alverdy J. Quality of life after gastric bypass surgery: a cross-sectional study. Obes Res 2002;10:1135–1142.PubMedCrossRefGoogle Scholar
  74. 74.
    Dixon J, Dixon M, O’Brien P. Depression in association with severe obesity changes with weight loss. Arch Intern Med 2003;163:2058–2065.PubMedCrossRefGoogle Scholar
  75. 75.
    Sampalis JS, Liberman M, Auger S, et al. The impact of weight reduction surgery on health-care costs in morbidly obese patients. Obes Surg 2004;14(7):939–947.PubMedCrossRefGoogle Scholar
  76. 76.
    Zingmond DS, McGory ML, Ko CY. Hospitalization before and after gastric bypass surgery. JAMA 2005;294:1918–1924.PubMedCrossRefGoogle Scholar
  77. 77.
    Encinosa WE, Bernard DM, Chen CC, et al. Healthcare utilization and outcomes after bariatric surgery. Med Care 2006;44(8):706–712.PubMedCrossRefGoogle Scholar
  78. 78.
    Wolfe B, Morton J. Weighing in on bariatric surgery: procedure use, readmission rates, and mortality. JAMA 2005;294(15):1960–1963.PubMedCrossRefGoogle Scholar
  79. 79.
    Clegg A, Colquitt J, Sidhu M, et al. Clinical and cost effectiveness of surgery for morbid obesity: a systematic review and economic evaluation. Int J Obes Relat Metab Disord 2003;27(10):1167–1177.PubMedCrossRefGoogle Scholar
  80. 80.
    Craig BM, Tseng DS. Cost-effectiveness of gastric bypass for severe obesity. Am J Med 2002;113(6):491–498.PubMedCrossRefGoogle Scholar
  81. 81.
    Vanek VW. State laws on insurance coverage for bariatric surgery: help or a hindrance? Surg Obes Relat Disord 2005;1(4):424–429.CrossRefGoogle Scholar
  82. 82.
    Giusti V, De Lucia A, Di Vetta V, et al. Impact of preoperative teaching on surgical option of patients qualifying for bariatric surgery. Obes Surg 2004;14:1241–1246.PubMedCrossRefGoogle Scholar
  83. 83.
    Van Hout GC, Verschure SK, van Heck GL. Psychosocial predictors of success following bariatric surgery. Obes Surg 2005;15:552–560.PubMedCrossRefGoogle Scholar
  84. 84.
    Delin CR, Watts JM, Bassett DL. An exploration of the outcomes of gastric bypass surgery for morbid obesity: patient characteristics and indices of success. Obes Surg 1995;5(2):159–170.PubMedCrossRefGoogle Scholar
  85. 85.
    Dixon JB, Dixon ME, O’Brien PE. Pre-operative predictors of weight loss at 1-year after Lap-Band surgery. Obes Surg 2001;11(2):200–207.PubMedCrossRefGoogle Scholar
  86. 86.
    Liu JH, Zingmond D, Etzioni DA, et al. Characterizing the performance and outcomes of obesity surgery in California. Am Surg 2003;69:823–828.PubMedGoogle Scholar
  87. 87.
    Nguyen NT, Paya M, Stevens CM, Mavandadi S, Zainabadi K, Wilson SE. The relationship between hospital volume and outcome in bariatric surgery at academic medical centers. Ann Surg 2004;240:586–593.PubMedGoogle Scholar
  88. 88.
    Courcoulas A, Schuchert M, Gatti G, Luketich J. The relationship of surgeon and hospital volume to outcome after gastric bypass surgery in Pennsylvania: a 3-year summary. Surgery (St. Louis) 2003;134:613–621.PubMedCrossRefGoogle Scholar
  89. 89.
    Fernandez AZ Jr, Demaria EJ, Tichansky DS, et al. Multivariate analysis of risk factors for death following gastric bypass for treatment of morbid obesity. Ann Surg 2004;239:698–703.PubMedCrossRefGoogle Scholar
  90. 90.
    Poulose BK, Griffin MR, Zhu Y, et al. National analysis of adverse patient safety events in bariatric surgery. Am Surg 2005;71:406–413.PubMedGoogle Scholar
  91. 91.
    Livingston EH, Ko CY. Assessing the relative contribution of individual risk factors on surgical outcome for gastric bypass surgery: a baseline probability analysis. J Surg Res 2002;105:48–52.PubMedCrossRefGoogle Scholar
  92. 92.
    Ballantyne GH, Svahn J, Capella RF, et al. Predictors of prolonged hospital stay following open and laparoscopic gastric bypass for morbid obesity: body mass index, length of surgery, sleep apnea, asthma, and the metabolic syndrome. Obes Surg 2004;14(8):1042–1050.PubMedCrossRefGoogle Scholar
  93. 93.
    Benotti PN, Wood GC, Rodriguez H, et al. Perioperative outcomes and risk factors in gastric surgery for morbid obesity: a 9-year experience. Surgery (St. Louis) 2006;139(3):340–346.PubMedCrossRefGoogle Scholar
  94. 94.
    Livingston EH, Huerta S, Arthur D, et al. Male gender is a predictor of morbidity and age a predictor of mortality for patients undergoing gastric bypass surgery. Ann Surg 2002;236(5):576–582.PubMedCrossRefGoogle Scholar
  95. 95.
    Livingston EH, Langert J. The impact of age and Medicare status on bariatric surgical outcomes. Arch Surg 2006;141(11):1115–1120; discussion 1121.PubMedCrossRefGoogle Scholar
  96. 96.
    Morton JM, Hagedorn J, Encarnacion B, et al. Post-operative gastric bypass complications do not affect weight loss. Presented at 11th Annual IFSO Meeting, Sydney, Australia, August 2006.Google Scholar
  97. 97.
    Flum DR, Salem L, Elrod JAB, et al. Early mortality among Medicare beneficiaries undergoing bariatric surgery. JAMA 2005;294:1903–1908.PubMedCrossRefGoogle Scholar
  98. 98. (accessed Dec. 2006).Google Scholar
  99. 99.
    Hsu GP, Morton JM, Jin L, Safadi BY, Satterwhite TS, Curet MJ. Laparoscopic Roux-en-Y gastric bypass: differences in outcome between attendings and assistants of different training backgrounds. Obes Surg 2005;15:1104–1110.PubMedCrossRefGoogle Scholar
  100. 100.
    Schauer P, Ikramuddin S, Hamad G, Gourash W. The learning curve for laparoscopic Roux-en-Y gastric bypass is 100 cases. Surg Endosc 2003;17:212–215.PubMedCrossRefGoogle Scholar
  101. 101.
    Ballantyne GH, Ewing D, Capella RF, et al. The learning curve measured by operating times for laparoscopic and open gastric bypass: roles of surgeon’s experience, institutional experience, body mass index and fellowship training. Obes Surg 2005;15(2):172–182.PubMedCrossRefGoogle Scholar
  102. 102.
    Alami RS, Morton JM, Schuster R, Lie J, Sanchez BR, Curet MJ. Is there a benefit to pre-operative weight loss in gastric bypass patients? A prospective randomized trial. Surg Obes Relat Disord 2007;3(2):141–145; discussion 145–146.CrossRefGoogle Scholar
  103. 103.
    Nguyen NT, Morton JM, Wolfe BM, Schirmer B, Ali M, Traverso LW. The SAGES Bariatric Surgery Outcome Initiative. Surg Endosc 19:1429–1438, 2005PubMedCrossRefGoogle Scholar
  104. 104.
    Hutter M, Crane M, Keenan M. Data collection systems for weight loss surgery: an evidence-based assessment. Obes Res 2005;13(2):301–305.PubMedCrossRefGoogle Scholar
  105. 105.
    Puzziferri N, Austrheim-Smith IT, Wolfe BM, Wilson SE, Nguyen NT. Three-year follow-up of a prospective randomized trial comparing laparoscopic versus open gastric bypass. Ann Surg 2006;243:181–188.PubMedCrossRefGoogle Scholar
  106. 106.
    Lujan JA, Frutos MD, Hernandez Q, et al. Laparoscopic versus open gastric bypass in the treatment of morbid obesity: a randomized prospective study. Ann Surg 2004;239(4):433–437.PubMedCrossRefGoogle Scholar
  107. 107.
    Westling A, Gustavs.son S. Laparoscopic vs. open Roux-en-Y gastric bypass: a prospective, randomized trial. Obes Surg 2001;11(3):284–292.PubMedCrossRefGoogle Scholar
  108. 108.
    Brolin RE. Laparoscopic versus open gastric bypass to treat morbid obesity. Ann Surg 2004;239(4):438–440.PubMedCrossRefGoogle Scholar
  109. 109.
    Sanchez BR, Morton J, Curet MJ, Alami RS, Safadi BY. Incidental finding of gastrointestinal stromal tumors (GISTs) during laparoscopic gastric bypass. Obes Surg 2005;10(15):1384–1388.CrossRefGoogle Scholar
  110. 110.
    Brolin RE, Kenler HA, Gorman JH, et al. Long-limb gastric bypass in the superobese. A prospective randomized study. Ann Surg 1992;215(4):387–395.PubMedCrossRefGoogle Scholar
  111. 111.
    Choban PS, Flancbaum L. The effect of Roux limb lengths on outcome after Roux-en-Y gastric bypass: a prospective, randomized clinical trial. Obes Surg 2002;12(4):540–545.PubMedCrossRefGoogle Scholar
  112. 112.
    Inabnet WB, Quinn T, Gagner M, et al. Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths. Obes Surg 2005;15(1):51–57.PubMedCrossRefGoogle Scholar
  113. 113.
    Christou NV, Look D, Maclean LD. Weight gain after short-and long-limb gastric bypass in patients followed for longer than 10 years. Ann Surg 2006;244(5):734–740.PubMedCrossRefGoogle Scholar
  114. 114.
    Fobi MA, Lee H, Igwe D Jr, et al. Prospective comparative evaluation of stapled versus transected silastic ring gastric bypass: 6-year follow-up. Obes Surg 2001;11(1):18–24.PubMedCrossRefGoogle Scholar
  115. 115.
    Sapala JA, Wood MH, Schuhknecht MP, et al. Fatal pulmonary embolism after bariatric operations for morbid obesity. Obes Surg 2003;13:819–825.PubMedCrossRefGoogle Scholar
  116. 116.
    Kalfarentzos F, Stavropoulou F, Yarmenitis S, et al. Prophylaxis of venous thromboembolism using two different doses of low-molecular-weight heparin (nadroparin) in bariatric surgery: a prospective randomized trial. Obes Surg 2001;11(6):670–676.PubMedCrossRefGoogle Scholar
  117. 117.
    LaMasters T, Lau J, Lemmens H, Morton JM. Use of local anesthetic infusion pump in laparoscopic Roux-en-Y gastric bypass: a prospective double-blinded randomized placebo controlled trial. Surg Endosc 2007, in press.Google Scholar
  118. 118.
    Miller K, Hell E, Lang B, et al. Gallstone formation prophylaxis after gastric restrictive procedures for weight loss: a randomized double-blind placebo-controlled trial. Ann Surg 2003;238(5):697–702.PubMedCrossRefGoogle Scholar
  119. 119.
    Sugerman Hj, Brewer WH, Shiffman ML, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995;169(1):91–96; discussion 96–97.PubMedCrossRefGoogle Scholar
  120. 120.
    Brolin RE, Gorman JH, Gorman RC, et al. Prophylactic iron supplementation after Roux-en-Y gastric bypass: a prospective, double-blind, randomized study. Arch Surg 1998;133(7):740–744.PubMedCrossRefGoogle Scholar
  121. 121.
    de Wit LT, Mathus-Vliegen L, Hey C, et al. Open versus laparoscopic adjustable silicone gastric banding: a prospective randomized trial for treatment of morbid obesity. Ann Surg 1999;230(6):800–805; discussion 805–807.PubMedCrossRefGoogle Scholar
  122. 122.
    Weiss HG, Nehoda H, Labeck B, et al. Adjustable gastric and esophagogastric banding: a randomized clinical trial. Obes Surg 2002;12(4):573–578.PubMedCrossRefGoogle Scholar
  123. 123.
    Ren CJ, Weiner, Allen JW. Favorable early results of gastric banding for morbid obesity: the American experience. Surg Endosc 2004;18(3):543–546.PubMedCrossRefGoogle Scholar
  124. 124.
    DeMaria EJ, Sugerman HJ, Meador JG, et al. High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity. Ann Surg 2001;233(6):809–818.PubMedCrossRefGoogle Scholar
  125. 125.
    O’Brien PE, Dixon JB, Laurie C, et al. A prospective randomized trial of placement of the laparoscopic adjustable gastric band: comparison of the perigastric and pars flaccida pathways. Obes Surg 2005;15(6):820–826.PubMedCrossRefGoogle Scholar
  126. 126.
    Kirchmayr W, Klaus A, Muhlmann G, et al. Adjustable gastric banding: assessment of safety and efficacy of bolus-filling during follow-up. Obes Surg 2004;14(3):387–391.PubMedCrossRefGoogle Scholar
  127. 127.
    Blanco-Engert R, Weiner S, Pomhoff I, et al. Outcome after laparoscopic adjustable gastric banding, using the Lap-Band and the Heliogast band: a prospective randomized study. Obes Surg 2003;13(5):776–779.PubMedCrossRefGoogle Scholar
  128. 128.
    Ponson AE, Janssen IM, Klinkenbijl JH. Laparoscopic adjustable gastric banding: a prospective comparison of two commonly used bands. Obes Surg 2002;12(4):579–582.PubMedCrossRefGoogle Scholar
  129. 129.
    Suter M, Giusti V, Worreth M, et al. Laparoscopic gastric banding: a prospective, randomized study comparing the Lapband and the SAGB: early results. Ann Surg 2005;241(1):55–62.PubMedGoogle Scholar
  130. 130.
    Cottam D, Qureshi FG, Mattar SG, et al. Laparoscopic sleeve gastrectomy as an initial weight-loss procedure for high-risk patients with morbid obesity. Surg Endosc 2006;20(6):859–863.PubMedCrossRefGoogle Scholar
  131. 131.
    Roa PE, Kaidar-Person O, Pinto D, et al. Laparoscopic sleeve gastrectomy as treatment for morbid obesity: technique and short-term outcome. Obes Surg 2006;16(10):1323–1326.PubMedCrossRefGoogle Scholar
  132. 132.
    Himpens J, Dapri G, Cadiere GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg 2006;16(11):1450–1456.PubMedCrossRefGoogle Scholar
  133. 133.
    Milone L, Strong V, Gagner M. Laparoscopic sleeve gastrectomy is superior to endoscopic intragastric balloon as a first stage procedure for super-obese patients (BMI > or = 50). Obes Surg 2005;15(5):612–617.PubMedCrossRefGoogle Scholar
  134. 134.
    Kirby DF, Wade JB, Mills PR, et al. A prospective assessment of the Garren-Edwards gastric bubble and bariatric surgery in the treatment of morbid obesity. Am Surg 1990;56(10):575–580.PubMedGoogle Scholar
  135. 135.
    Lindor KD, Hughes RW Jr, Ilstrup DM, et al. Intragastric balloons in comparison with standard therapy for obesity—a randomized, double-blind trial. Mayo Clin Proc 1987;62(11):992–996.PubMedGoogle Scholar
  136. 136.
    Marshall JB, Schreiber H, Kolozsi W, et al. A prospective, multi-center clinical trial of the Taylor intragastric balloon for the treatment of morbid obesity. Am J Gastroenterol 1990;85(7):833–837.PubMedGoogle Scholar
  137. 137.
    Mathus-Vliegen EM, Tytgat GN, Veldhuyzen-Offermans EA. Intragastric balloon in the treatment of super-morbid obesity. Double-blind, sham-controlled, crossover evaluation of 500-milliliter balloon. Gastroenterology 1990;99(2):362–369.PubMedGoogle Scholar
  138. 138.
    Mathus-Vliegen EM, Tytgat GN. Intragastric balloon for treatment-resistant obesity: safety, tolerance, and efficacy of 1-year balloon treatment followed by a 1-year balloon-free follow-up. Gastrointest Endosc 2005;61(1):19–27.PubMedCrossRefGoogle Scholar
  139. 139.
    Genco A, Cipriano M, Bacci V, et al. BioEnterics intragastric balloon (BIB): a short-term, double-blind, randomised, controlled, crossover study on weight reduction in morbidly obese patients. Int J Obes (Lond) 2006;30(1):129–133.CrossRefGoogle Scholar
  140. 140.
    Cigaina W, Pinato G, Rigo V, et al. Gastric peristalsis control by mono situ electrical stimulation: a preliminary study. Obes Surg 1996;6(3):247–249.PubMedCrossRefGoogle Scholar
  141. 141.
    De Luca M, Segato G, Busetto L, et al. Progress in implantable gastric stimulation: summary of results of the European multi-center study. Obes Surg 2004;14(suppl 1):S33–S39.PubMedCrossRefGoogle Scholar
  142. 142.
    Shikora SA. “What are the Yanks doing?” the U.S. experience with implantable gastric stimulation (IGS) for the treatment of obesity: update on the ongoing clinical trials. Obes Surg 2004;14(suppl 1):S40–S48.PubMedCrossRefGoogle Scholar
  143. 143.
    Sugerman HJ, DeMaria EJ, Kellum JM, et al. Effects of bariatric surgery in older patients. Ann Surg 2004;240:243–247.PubMedCrossRefGoogle Scholar
  144. 144.
    Fielding GA. Laparoscopic adjustable gastric banding for massive superobesity (>60 body mass index kg/m2). Surg Endosc 2003;17:1541–1545.PubMedCrossRefGoogle Scholar
  145. 145.
    Dolan K, Hatzifotis M, Newbury L. A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 2004;14:165–169.PubMedCrossRefGoogle Scholar
  146. 146.
    Mongol P, Chosidow D, Marmuse JP. Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding in the superobese: a comparative study of 290 patients. Obes Surg 2005;15:76–81.CrossRefGoogle Scholar
  147. 147.
    Regan JP, Inabnet WB, Gagner M, et al. Early experience with 2-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient. Obes Surg 2003;13:861–864.PubMedCrossRefGoogle Scholar
  148. 148.
    Must A, Jacques PF, Dallal GE, Bajema CJ, Dietz WH. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med 1992;327(19):1350–1355.PubMedCrossRefGoogle Scholar
  149. 149.
    Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relationship of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999;103(6):1175–1182.PubMedCrossRefGoogle Scholar
  150. 150.
    Schwimmer JB, Burwinkle TM, Varni JW. Health-related quality of life of severely obese children and adolescents. JAMA 2003;289(14):1813–1819.PubMedCrossRefGoogle Scholar
  151. 151.
    Gortmaker SL. Social and economic consequences of overweight in adolescence and young adulthood. N Engl J Med 1993;329(14):1008–1012.PubMedCrossRefGoogle Scholar
  152. 152.
    Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics 2004;114(1):217–223.PubMedCrossRefGoogle Scholar
  153. 153.
    Lawson ML. One year outcomes of Roux-en-Y gastric bypass for morbidly obese adolescents. J Pediatr Surg 2006;41(1):137–143.PubMedCrossRefGoogle Scholar
  154. 154.
    Sheiner E, Levy A, Silverberg D, et al. Pregnancy after bariatric surgery is not associated with adverse perinatal outcome. Am J Obstet Gynecol 2004;190(5):1335–1340.PubMedCrossRefGoogle Scholar
  155. 155.
    Martin LF, Finigan KM, Nolan TE. Pregnancy after adjustable gastric banding. Obstet Gynecol 2000;95(6):927–930.PubMedCrossRefGoogle Scholar
  156. 156.
    Martin L. Gastric bypass as a maternal risk factor for neural tube defects. Lancet 1988;1(8586):640–641.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • John Morton
    • 1
  1. 1.Department of Bariatric SurgeryStanford School of MedicineStanfordUSA

Personalised recommendations